Context Therapeutics Inc.

Direct answer

Context Therapeutics Inc. is publicly traded on NASDAQ under the ticker CNTX.

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6...

Can you invest in Context Therapeutics Inc.?

Yes. Context Therapeutics Inc. is publicly traded on NASDAQ under the ticker CNTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Context Therapeutics Inc.

Detailed equity research is provided by MarketSnap.